Poels LG - Search Results

1

In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.

Nässander UK, Steerenberg PA, Poppe H, Storm G, Poels LG, De Jong WH, Crommelin DJ. Nässander UK, et al. Among authors: poels lg. Cancer Res. 1992 Feb 1;52(3):646-53. Cancer Res. 1992. PMID: 1732053

2

Design of immunoliposomes directed against human ovarian carcinoma.

Nässander UK, Steerenberg PA, De Jong WH, Van Overveld WO, Te Boekhorst CM, Poels LG, Jap PH, Storm G. Nässander UK, et al. Among authors: poels lg. Biochim Biophys Acta. 1995 Apr 12;1235(1):126-39. doi: 10.1016/0005-2736(94)00300-e. Biochim Biophys Acta. 1995. PMID: 7718600 Free article.

3

Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.

Steerenberg PA, De Jong WH, Geerse E, Aleva BJ, Besselink CM, Van Rens BT, Rutten VP, Poels LG, Scheper RJ, Den Otter W, et al. Steerenberg PA, et al. Among authors: poels lg. Cancer Immunol Immunother. 1990;32(2):95-104. doi: 10.1007/BF01754205. Cancer Immunol Immunother. 1990. PMID: 1963114 Free PMC article.

4

Tumor infiltrating leukocytes (tils) during progressive tumor growth and BCG-mediated tumor regression.

Steerenberg PA, De Jong WH, Elgersma A, Burger R, Poels LG, Claessen AM, Den Otter W, Ruitenberg EJ. Steerenberg PA, et al. Among authors: poels lg. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(4):185-94. doi: 10.1007/BF02899404. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990. PMID: 1980168

5

Changing tumour antigen expression in metastatic hepatocellular carcinoma cells of the guinea pig.

van de Molengraft F, Poels LG, van Niekerk CC, Mungyer G, Steerenberg P, Jap PH. van de Molengraft F, et al. Among authors: poels lg. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56(4):211-9. doi: 10.1007/BF02890020. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989. PMID: 2469249

6

Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.

Massuger LF, Boerman OC, Corstens FH, Verheijen RH, Claessens RA, Poels LG, van den Broek WJ, Kenemans P. Massuger LF, et al. Among authors: poels lg. Anticancer Res. 1991 Nov-Dec;11(6):2051-7. Anticancer Res. 1991. PMID: 1776839

7

Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.

Boerman O, Massuger L, Makkink K, Thomas C, Kenemans P, Poels L. Boerman O, et al. Anticancer Res. 1990 Sep-Oct;10(5A):1289-95. Anticancer Res. 1990. PMID: 2241105

8

Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids.

Boerman O, Makkink K, Massuger L, Thomas C, Kenemans P, Hanselaar T, Poels L. Boerman O, et al. Anticancer Res. 1989 May-Jun;9(3):551-8. Anticancer Res. 1989. PMID: 2764501

9

Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.

Massuger LF, Kenemans P, Claessens RA, Verheijen RH, Schijf CP, Strijk SP, Poels LG, van Hoesel RG, Corstens FH. Massuger LF, et al. Among authors: poels lg. J Nucl Med. 1990 Nov;31(11):1802-10. J Nucl Med. 1990. PMID: 2230993 Free article. Clinical Trial.

10

Marker profile of mesothelial cells versus ovarian carcinoma cells.

van Niekerk CC, Jap PH, Thomas CM, Smeets DF, Ramaekers FC, Poels LG. van Niekerk CC, et al. Among authors: poels lg. Int J Cancer. 1989 Jun 15;43(6):1065-71. doi: 10.1002/ijc.2910430619. Int J Cancer. 1989. PMID: 2659540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page